Primary Coenzyme Q10 Deficiency Overview
- PMID: 28125198
- Bookshelf ID: NBK410087
Primary Coenzyme Q10 Deficiency Overview
Excerpt
The purpose of this overview is to:
- 1
Briefly describe the clinical characteristics of primary coenzyme Q10 (CoQ10) deficiency.
- 2
Increase the awareness of clinicians regarding genetic causes of primary CoQ10 deficiency.
- 3
Review the differential diagnosis of primary CoQ10 deficiency with a focus on genetic conditions.
- 4
Provide an evaluation strategy to identify the genetic cause of primary CoQ10 deficiency in a proband.
- 5
Review management of primary CoQ10 deficiency, including targeted pharmacologic treatment with high-dose oral CoQ10 supplementation and supportive treatment.
- 6
Inform genetic counseling of family members of an individual with primary CoQ10 deficiency.
Copyright © 1993-2025, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.
Sections
- Summary
- 1. Clinical Characteristics of Primary Coenzyme Q10 Deficiency
- 2. Genetic Causes of Primary Coenzyme Q10 Deficiency
- 3. Differential Diagnosis of Primary Coenzyme Q10 Deficiency
- 4. Evaluation Strategies to Identify the Genetic Cause of Primary Coenzyme Q10 Deficiency in a Proband
- 5. Management
- 6. Genetic Counseling
- Resources
- Chapter Notes
- References
References
-
- Acosta MJ, Vazquez Fonseca L, Desbats MA, Cerqua C, Zordan R, Trevisson E, Salviati L. Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta. 2016;1857:1079-85. - PubMed
-
- Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, Fang H, Song X, Cattran DC, Avila-Casado C, Paterson AD, Nitschké P, Bole-Feysot C, Cochat P, Esteve-Rudd J, Haberberger B, Allen SJ, Zhou W, Airik R, Otto EA, Barua M, Al-Hamed MH, Kari JA, Evans J, Bierzynska A, Saleem MA, Böckenhauer D, Kleta R, El Desoky S, Hacihamdioglu DO, Gok F, Washburn J, Wiggins RC, Choi M, Lifton RP, Levy S, Han Z, Salviati L, Prokisch H, Williams DS, Pollak M, Clarke CF, Pei Y, Antignac C, Hildebrandt F. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Invest. 2013;123:5179-89. - PMC - PubMed
-
- Auré K, Benoist JF, Ogier de Baulny H, Romero NB, Rigal O, Lombes A. Progression despite replacement of a myopathic form of coenzyme Q10 defect. Neurology. 2004;63:727-9. - PubMed
-
- Brea-Calvo G, Haack TB, Karall D, Ohtake A, Invernizzi F, Carrozzo R, Kremer L, Dusi S, Fauth C, Scholl-Bürgi S, Graf E, Ahting U, Resta N, Laforgia N,Verrigni D, Okazaki Y, Kohda M, Martinelli D, Freisinger P, Strom TM, Meitinger T, Lamperti C, Lacson A, Navas P, Mayr JA, Bertini E, Murayama K, Zeviani M, Prokisch H, Ghezzi D. COQ4 mutations cause a broad spectrum of mitochondrial disorders associated with CoQ10 deficiency. Am J Hum Genet. 2015; 96:309-17. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Medical